Assessment of cytotoxic properties of safranal and nanoliposomal safranal in various cancer cell lines

Phytotherapy Research

Volumn 27, Issue 12, 2013, Pages 1868-1873

  Malaekeh Nikouei, Bizhan ^a   Mousavi, Seyed Hadi ^b,c   Shahsavand, Shabnam ^d   Mehri, Soghra ^a   Nassirli, Horiyeh ^e   Moallem, Seyed Adel ^a,c,e  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

apoptosis; cytotoxicity; nanoliposome; saffron; safranal

Indexed keywords

LIPOSOME; PLANT MEDICINAL PRODUCT; SAFRANAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL AGGREGATION; CELL VIABILITY; CONTROLLED STUDY; CROCUS SATIVUS; CYTOTOXICITY; DNA FRAGMENTATION; ENCAPSULATION; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; MORPHOLOGY; MOUSE; NONHUMAN; PARTICLE SIZE; QUANTITATIVE ANALYSIS;

CROCUS SATIVUS;

APOPTOSIS; CYTOTOXICITY; NANOLIPOSOME; SAFFRON; SAFRANAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CROCUS; CYCLOHEXENES; DRUG CARRIERS; HELA CELLS; HUMANS; INHIBITORY CONCENTRATION 50; LIPOSOMES; MCF-7 CELLS; MICE; NANOPARTICLES; PLANT EXTRACTS; PROPIDIUM; TERPENES; TETRAZOLIUM SALTS;

EID: 84890555234     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4945     Document Type: Article

References (33)

1. Abdullaev FI,. 2002. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med 227: 20-25.
2. Abdullaev FI, Espinosa-Aguirre JJ,. 2004. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detec Prev 28: 426-432.
3. Anderson FA,. 2005. Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics. Int J Toxicol 24: 21-50.
4. Andresen TL, Jensen SS, Jorgensen K,. 2005. Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release. Prog Lipid Res 44: 68-97.
5. Assimopoulou AN, Sinakos Z, Papageorgiou VP,. 2005. Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res 19: 997-1000.
6. Boskabady MH, Aslani MR,. 2006. Relaxant effect of Crocus sativus (saffron) on guinea-pig tracheal chains and its possible mechanisms. J Pharm Pharmacol 58: 1385-1390.
7. Caballero-Ortega H, Pereda-Miranda R, Abdullaev FI,. 2007. HPLC quantification of major active components from 11 different saffron (Crocus sativus L.) sources. Food Chem 100: 1126-1131.
8. Chonn A, Cullis PR,. 1995. Recent advances in liposomal drug-delivery systems. Curr Opin Biotechnol 6: 698-708.
9. Chryssanthi DG, Lamari FN, Iatrou G, Pylara A, Karamanos NK, P Cordopatis,. 2007. Inhibition of breast cancer cell proliferation by style constituents of different crocus species. Anticancer Res 27: 357-362.
10. Crosasso P, Brusa P, Dosio F, et al,. 1997. Antitumoral activity of liposomes and immunoliposomes containing 5- fluorouridine prodrugs. J Pharm Sci 86: 832-839.
11. Escribano J, Alonso GL, Coca-Prados M, Fernandez JA,. 1996. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett 100: 23-30.
12. Farokhzad OC, Langer R,. 2009. Impact of nanotechnology on drug delivery. ACS Nano 3: 16-20.
13. Gabizon AA,. 1992. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52: 891-896.
14. Goyal P, Goyal K, Kumar SGV, Singh A, Katare OP, Mishra DN,. 2005. Liposomal drug delivery systems-Clinical applications. Acta Pharm 55: 1-25.
15. Gregoriadis G,. 1995. Engineering liposomes for drug delivery: Progress and problems. Trends Biotechnol 13: 527-537.
16. Hatziantoniou S, Dimas K, Georgopoulos A, Sotiriadou N, Demetzos C,. 2006. Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts. Pharmacol Res 53: 80-87.
17. Hosseinzadeh H, Ghenaati J,. 2006. Evaluation of the antitussive effect of stigma and petals of saffron (Crocus sativus) and its components, safranal and crocin in guinea pigs. Fitoterapia 77: 446-448.
18. Hosseinzadeh H, Sadeghnia HR,. 2005. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci 8: 394-399.
19. Hosseinzadeh H, Talebzadeh F,. 2005. Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia 76: 722-724.
20. Karanth H, Murthy RSR,. 2007. pH-Sensitive liposomes-Principle and application in cancer therapy. J Pharm Pharm 59: 469-483.
21. Malaekeh-Nikouei B, Jaafari MR, Tabassi SAS, Samiei A,. 2008. The enhancement of immunosuppressive effects of cyclosporine A on human T-cells using fusogenic liposomes. Colloids and Surfaces B. Biointerfaces 67: 238-244.
22. Matsingou C, Dimas K, Demetzos C,. 2006. Design andآ development of liposomes incorporating a bioactive labdane-type diterpene. In vitro growth inhibiting andآ cytotoxic activity against human cancer cell lines. Biomed Pharmacother 60: 191-199.
23. Moallem SA, Timcheh-Hariri A, Mahmoudi M, Hosseinzadeh H,. 2012. Effect of aqueous extract of Crocus sativus L. (saffron) stigma against subacute effect of diazinon on specific biomarkers in rats. Toxicol Ind Health, 0748233712452609, first published on July 10, 2012. DOI: 10.1177/ 0748233712452609
24. Mousavi SH, Tavakkol-Afshari J, Brook A, Jafari-Anarkooli I,. 2009a. Direct toxicity of Rose Bengal in MCF-7 cell line: Role of apoptosis. Food Chem Toxicol 47: 855-859.
25. Mousavi SH, Tavakkol-Afshari J, Brook A, Jafari-Anarkooli I,. 2009b. Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food Chem Toxicol 47: 1909-1913.
26. Nair SC, Salomi MJ, Varghese CD, Panikkar B, Panikkar KR,. 1992. Effect of saffron on thymocyte proliferation, intracellular glutathione levels and its antitumor activity. Biofactors 4: 51-54.
27. New RRC,. 1997. Liposomes: a practical approach. Oxford University Press: Oxford.
28. Rios JL, Recio MC, Giner RM, Manez S,. 1996. An update review of saffron and its active constituents. Phytother Res 10: 189-193.
29. Tavakkol-Afshari J, Brook A, Mousavi SH,. 2008. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem Toxicol 46: 3443-3447.
30. Timcheh Hariri A, Moallem SA, Mahmoudi M, Hosseinzadeh H,. 2011. The effect of crocin and safranal, constituents of saffron, against subacute effect of diazinon on hematological and genotoxicity indices in rats. Phytomedicine 18: 499-504.
31. Torchilin VP,. 2005. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4: 145-160.
32. Turanek J, Wang XF, Knotigova P, et al,. 2009. Liposomal formulation of α-tocopheryl maleamide: In vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice. Toxicol Appl Pharmacol 237: 249-257.
33. Yuan F, Dellian M, Fukumura D, et al,. 1995. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res 55: 3752-3756.